The benefits of approved COVID-19 vaccines still far outweigh the risks, experts say following a recently reported death in South Africa linked to Johnson & Johnson’s COVID-19 vaccine. Adele Baleta reports.
Initially hamstrung by low and uncertain supplies of COVID-19 vaccines, government is arguably now in a better position to campaign actively to accelerate vaccine demand, albeit in the midst of an often-harmful viral “infodemic”. Chris Bateman asks what can be done to boost demand for the jab.
The new and more contagious Delta variant has now surpassed the Beta variant to become the dominant SARS-CoV-2 variant in South Africa. Laura Lopez Gonzalez pulled together answers to eight common questions asked about this new variant.
It has been a week since South Africa started its mass rollout for 60-year-olds and older. Nathan Geffen and Marcus Low assess the rollout so far.
Starting now, hundreds of thousands of COVID-19 vaccines will be arriving in South Africa weekly. Rather than spending energy and resources policing who gets them, we should be focusing on getting the vaccines as fast as possible into willing arms. Don’t try to micro-manage the rollout, writes Nathan Geffen and Marcus Low.
With phase two of the country’s vaccination rollout set to start on Monday, 17 May, provinces are gearing up for the largest adult vaccination push the country has ever seen. Elri Voigt provides an update on preparations for the next phase in the nine provinces and progress made in vaccinating healthcare workers through the Sisonke implementation study.
Strict monitoring and surveillance systems for the safety of all vaccines, including those for COVID-19, are in place during vaccine trials as well as once vaccines are rolled out more widely. Adele Baleta takes a look at how vaccine-related adverse events are monitored in South Africa.
The decision to “pause” the rollout of vaccines is perplexing. Every day the rollout is delayed results in infections and deaths that could have been prevented.
